Produkty 1048973-04-1

CAS 1048973-04-1 występuje w naszej ofercie pod nazwami: Lovastatin EP Impurity F, O-Des(2-methylbutyryl) O-((Z)-2-methyl-2-butenoyl) Lovastatin, Lovastatin impurity F (ep). Oferty producentów: Chemat Brand, TRC, Biosynth. Dostępne opakowania: on request, 250mg, 50mg, 100mg.

Lovastatin EP Impurity F
Chemat Brand
  • opakowanie: on request
  • Warianty: 1
Zobacz produkt
O-Des(2-methylbutyryl) O-((Z)-2-methyl-2-butenoyl) Lovastatin
TRC
  • opakowanie: 250mg
  • Warianty: 1
Zobacz produkt
Lovastatin impurity F (ep)
Biosynth
  • opakowanie: 50mg, 100mg
  • Warianty: 2
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

[(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (E)-2-methylbut-2-enoate (CAS 1048973-04-1) to związek chemiczny o wzorze sumarycznym C24H34O5 i masie molowej 402.5 g/mol. Nazwa systematyczna IUPAC: [(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (E)-2-methylbut-2-enoate. InChIKey: JSVUTGMIKPKXNQ-ORSWIJFBSA-N.

Dane identyfikacyjne
Wzór sumarycznyC24H34O5
Masa molowa402.5 g/mol
Nazwa IUPAC[(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (E)-2-methylbut-2-enoate
InChIKeyJSVUTGMIKPKXNQ-ORSWIJFBSA-N
SMILESC/C=C(\C)/C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C

Dane obliczone przez PubChem (NCBI)

Synonimy: Lovastatin impurity F [EP], LOVASTATIN IMPURITY F [EP IMPURITY]
Izomery (ten sam wzór sumaryczny)
(4R)-4-[(5S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-3,7,12-trioxo-1,2,4,5,6,8,9,11,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pentanoic acid C24H34O5
[(1R,6S,8R,9S,10R,13S,14S,17R)-17-acetyl-1-hydroxy-6,10,13-trimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate C24H34O5
methyl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]hept-5-enoate C24H34O5
[(2S,6S,8R,9S,10R,13S,14S,17R)-17-acetyl-2-hydroxy-6,10,13-trimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate C24H34O5
[(8R,9S,10R,13S,14S,17R)-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] propanoate C24H34O5
[2-[(8R,9S,10R,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] propanoate C24H34O5
[(6R,8R,9S,10R,13S,14S,17R)-17-acetyl-6-hydroxy-6,10,13-trimethyl-3-oxo-1,2,7,8,9,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl] acetate C24H34O5
[(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-6-hydroxy-6,10,13-trimethyl-3-oxo-1,2,7,8,9,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl] acetate C24H34O5
(13S,17R)-13-methyl-17-(2-methyl-1,3-dioxolan-2-yl)spiro[1,2,4,6,7,8,12,14,15,16-decahydrocyclopenta[a]phenanthrene-3,2'-1,3-dioxolane]-17-ol C24H34O5
(8S,13S,14S,17S)-13-methyl-17-(2-methyl-1,3-dioxolan-2-yl)spiro[1,2,4,6,7,8,12,14,15,16-decahydrocyclopenta[a]phenanthrene-3,2'-1,3-dioxolane]-17-ol C24H34O5
[(1S,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-7-methyl-3-methylidene-2,7,8,8a-tetrahydro-1H-naphthalen-1-yl] (2S)-2-methylbutanoate C24H34O5
(4R,6'R,8'R,9'S,10'R,13'S,14'S)-6'-hydroxy-2,2,10',13'-tetramethylspiro[1,3-dioxane-4,17'-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene]-3',5-dione C24H34O5